Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

910.00p
   
  • Change Today:
    106.00p
  • 52 Week High: 915.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.75m
  • Volume: 1,193,438
  • Market Cap: £1,098.85m
  • RiskGrade: 125
  • Beta: 1.74

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Registrars: Capita Registrars

Key Personnel

CEO: Frank Mathias
CFO: Lucinda (Lucy) Crabtree
Chairman: Roch Doliveux
Independent Non-Executive Director: Namrata P Patel
Independent Non-Executive Director: Heather Preston
Senior Independent Director: Dame Kay Davies
Non-Executive Dir: Laurence Espinasse, Colin Bond , Peter Soelkner

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:OXBL
ISIN: GB00BDFBVT43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 910.00p
Change Today 106.00p
% Change 13.18 %
52 Week High 915.00p
52 Week Low 232.50p
Volume 1,193,438
Shares Issued 120.75m
Market Cap £1,098.85m
Beta 1.74
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

OXB Dividends

No dividends found

Trades for 15-Jan-2026

Time Volume / Share Price
12:43 40 @ 908.00p
12:43 570 @ 910.00p
12:43 155 @ 909.76p
12:43 8 @ 910.00p
12:42 2 @ 915.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page